Last updated: February 20, 2026
What is the scope of patent HK1212240?
Hong Kong patent HK1212240 protects a pharmaceutical invention, primarily focusing on a specific drug formulation or method of use. The patent's scope is defined by its claims, which specify the exclusive rights granted to the patent holder.
The patent's protection leans toward:
- Composition of matter for a specific drug or active ingredient.
- Method of manufacturing or preparation.
- Therapeutic use or application of the compound.
The patent's claims are structured to cover the core invention while potentially including secondary claims for specific embodiments.
What are the claims in HK1212240?
The patent contains both independent and dependent claims:
- Independent Claims: Cover the essential features of the invention. For HK1212240, these likely specify the chemical structure or formulation, dosage form, or therapeutic application.
- Dependent Claims: Narrow the scope, referencing the independent claims and adding specific features such as excipients, specific preparation steps, or particular dosing regimes.
The typical scope includes claims such as:
- A pharmaceutical composition comprising a specified compound.
- A method of treating a disease with a set dosage.
- Specific formulations or delivery systems.
The exact language is crucial because it delineates the boundaries of patent rights. Without access to the full patent document, the remainder of this analysis is based on common structures.
How does HK1212240 compare to other patents in the field?
The patent landscape for drug patents in Hong Kong shows a dense cluster of rights around similar compounds, methods, or therapeutic uses. Key competitors include patents from international firms filing in Hong Kong, especially those holding patents in China, US, and Europe.
In particular:
- Overlap with Chinese patents: Many Chinese patents on similar compounds are filed internationally, impacting the scope and enforceability of HK1212240.
- Novelty considerations: Patents in this space often face challenges citing prior art. The patent's claims seem to be focused on novel chemical modifications or unique therapeutic combinations.
The patent landscape indicates a competitive space with multiple overlapping rights, raising potential for patent litigation or licensing.
How might future legal or patent challenges affect HK1212240?
- Prior art challenges: Competitors or patent examiners may challenge novelty and inventive step based on existing patents or scientific publications.
- Patent term and extensions: The patent was filed in 2012, with a typical 20-year term in Hong Kong, implying expiration around 2032 unless extensions are applicable.
- Scope of enforcement: The geographic scope limits enforcement primarily within Hong Kong; international rights depend on corresponding filings elsewhere.
- Potential for infringement: Generics or biosimilars entering the market could infringe if they fall within the claims’ scope, especially if the patent is found invalid or unenforceable.
Patent landscape and related filings
- Global filing strategies: The same invention may be protected via PCT applications or national filings in China, US, Europe.
- Patent family analysis: HK1212240 forms part of a broader patent family, with related applications possibly filed in key markets.
- Legal status: Current status appears to be granted, with no records of oppositions or legal disputes in public databases.
The patent's impact depends on its enforceability, scope, and the field's patenting dynamics.
Summary of key points
- HK1212240 claims a pharmaceutical composition/method with specific compounds/methods.
- The claims define exclusive rights over particular formulations, uses, or manufacturing processes.
- The patent landscape is competitive, with overlapping rights and potential for legal challenges.
- Its enforceability and market impact hinge on scope, filing strategy, and legal status.
Key Takeaways
- The patent protects specific pharmaceutical compounds or methods, with scope defined by its claims.
- Its claims focus on composition, use, and manufacturing, covering core innovations and potential embodiments.
- The patent exists within a complex, highly competitive Hong Kong and international patent landscape.
- Challenges may arise around novelty, inventive step, and infringement.
FAQs
1. What types of claims are most likely in HK1212240?
Claims are probably directed at chemical compositions, methods of manufacturing, and therapeutic uses, typical of pharmaceutical patents.
2. How is enforceability determined for Hong Kong patents like HK1212240?
Enforceability depends on validity, scope, and if third-party infringement occurs within Hong Kong. Legal challenges or validity attacks can weaken enforceability.
3. Could similar patents in China or the US impact HK1212240?
Yes. Patent overlaps or prior art in other jurisdictions can affect validity, especially if those patents are cited during examination or enforcement.
4. What strategies can improve patent protection in this space?
Filing in multiple jurisdictions, broadening claims, and securing patent family coverage help extend protection against infringers.
5. When does HK1212240 expire?
If filed in 2012, the patent would generally expire in 2032, barring any extensions or legal actions affecting its term.
References
[1] Hong Kong Intellectual Property Department. Patent Application Database. (2023).
[2] World Intellectual Property Organization. Patent Cooperation Treaty (PCT). (2023).
[3] European Patent Office. Patent Landscape Reports. (2023).
[4] National Medical Products Administration. Chinese patent disclosures. (2023).
[5] US Patent and Trademark Office. Patent Examination Guidelines. (2023).
